Novel diamides inspired by protein kinase inhibitors as anti-Trypanosoma cruzi agents: in vitro and in vivo evaluations
dc.creator | Torchelsen, Fernanda Karoline Vieira da Silva | |
dc.creator | Pedrosa, Tamiles Caroline Fernandes | |
dc.creator | Rodrigues, Michelle Peixoto | |
dc.creator | Aguiar, Alex Ramos de | |
dc.creator | Oliveira, Fabricio Marques de | |
dc.creator | Amarante, Giovanni Wilson | |
dc.creator | Sales Junior, Policarpo Ademar | |
dc.creator | Branquinho, Renata Tupinambá | |
dc.creator | Silva, Sirlaine Pio Gomes da | |
dc.creator | Silva, Andre Talvani Pedrosa da | |
dc.creator | Murta, Silvane Maria Fonseca | |
dc.creator | Martins, Felipe Terra | |
dc.creator | Silva, Andre Talvani Pedrosa da | |
dc.date.accessioned | 2023-11-10T12:29:23Z | |
dc.date.available | 2023-11-10T12:29:23Z | |
dc.date.issued | 2023-08-31 | |
dc.description.abstract | Background: Chagas disease is a life-threatening illness caused by Trypanosoma cruzi. The involvement of serine-/arginine-rich protein kinase in the T. cruzi life cycle is significant. Aims: To synthesize, characterize and evaluate the trypanocidal activity of diamides inspired by kinase inhibitor, SRPIN340. Material & Methods: Synthesis using a three-step process and characterization by infrared, nuclear magnetic resonance and high-resolution mass spectrometry were conducted. The selectivity index was obtained by the ratio of CC50/IC50 in two in vitro models. The most active compound, 3j, was evaluated using in vitro cytokine assays and assessing in vivo trypanocidal activity. Results:3j activity in the macrophage J774 lineage showed an anti-inflammatory profile, and mice showed significantly reduced parasitemia and morbidity at low compound dosages. Conclusion: Novel diamide is active against T. cruziin vitro and in vivo. | |
dc.identifier.citation | TORCHELSEN, Fernanda Karoline Vieira da Silva et al. Novel diamides inspired by protein kinase inhibitors as anti-Trypanosoma cruzi agents: in vitro and in vivo evaluations. Future Medicinal Chemistry, London, v. 15, n. 16, p. 1469-1489, 2023. DOI: 10.4155/fmc-2023-0090. Disponível em: https://www.future-science.com/doi/10.4155/fmc-2023-0090. Acesso em: 6 nov. 2023. | |
dc.identifier.doi | 10.4155/fmc-2023-0090 | |
dc.identifier.issn | 1756-8919 | |
dc.identifier.issn | e- 1756-8927 | |
dc.identifier.uri | https://www.future-science.com/doi/10.4155/fmc-2023-0090 | |
dc.language.iso | eng | |
dc.publisher.country | Gra-bretanha | |
dc.publisher.department | Instituto de Química - IQ (RMG) | |
dc.rights | Acesso Restrito | |
dc.subject | Chagas disease | |
dc.subject | Diamides | |
dc.subject | In vitro activity | |
dc.subject | In vivo activity | |
dc.subject | SRPIN340 | |
dc.subject | Trypanosoma cruzi | |
dc.title | Novel diamides inspired by protein kinase inhibitors as anti-Trypanosoma cruzi agents: in vitro and in vivo evaluations | |
dc.type | Artigo |
Arquivos
Licença do Pacote
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- license.txt
- Tamanho:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descrição: